Bayesian optimal designs for phase I clinical trials (Q3079157)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 5859256
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Bayesian optimal designs for phase I clinical trials |
scientific article; zbMATH DE number 5859256 |
Statements
Bayesian Optimal Designs for Phase I Clinical Trials (English)
0 references
1 March 2011
0 references
constrained optimal design
0 references
maximum tolerated dose
0 references
sequential design
0 references
0 references
0 references
0 references
0.8406758308410645
0 references
0.8358415961265564
0 references
0.8286197185516357
0 references
0.8286197185516357
0 references
0.8181495070457458
0 references
